Further studies utilizing a larger cohort and longer followup period could find a stronger relationship between breast cancer progression and Shh and IL-6 for testing their prognostic values and predictive therapeutic responses for these two biomarkers in combination with other biomarkers such as CA15.341. Here, SHH is linked to breast cancer.